Biodegradable Molecularly Imprinted Polymer Nanoparticles
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Conventional molecularly imprinted polymers used in nanoparticle form are non-degradable and can accumulate in organisms and the environment, and those using polysaccharides or protein-based building elements face limitations in affinity, selectivity, and biocompatibility, particularly causing inflammatory responses in vivo applications.
Innovation Solution
The development of biocompatible and biodegradable molecularly imprinted polymers in nanoparticle form, prepared by crosslinking functionalized polymers such as peptides and polypeptides, which are used as the primary building elements, allowing for specific and selective binding sites to be formed through a molecular imprinting process, enabling high affinity and selectivity towards target molecules.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If conventional monomers (meth)acrylates and (meth)acrylamides are used to prepare molecularly imprinted polymer nanoparticles, then high affinity and selectivity towards target molecules are achieved, but the polymers are not degradable and accumulate in organisms and the environment
Solution Approach 1:
The patent changes the chemical composition parameters of the building elements from conventional non-degradable (meth)acrylates and (meth)acrylamides to degradable alternatives such as polysaccharides (chitosan, dextran), amino acids, peptides, and proteins. This parameter change maintains the molecular imprinting capability while introducing biodegradability, resolving the contradiction between selectivity and environmental harm.
Solution Approach 2:
The patent employs composite building elements that combine the functional properties needed for molecular imprinting with biodegradable characteristics. By using hybrid materials such as polysaccharide-protein conjugates or amino acid-based polymers, the system achieves both high affinity/selectivity and biocompatibility, eliminating accumulation issues while preserving recognition capabilities.
2Object-generated harmful factors
If polysaccharides are used as building elements to improve biodegradability, then degradability and biocompatibility are enhanced, but affinity and selectivity are limited due to high repetitiveness of structure and limited functional groups
Solution Approach 1:
The patent merges polysaccharides with other biodegradable building elements such as amino acids, peptides, or proteins to create composite structures. This combination allows the polysaccharide backbone to provide biodegradability while the incorporated amino acid side chains or protein functional groups contribute diverse interaction capabilities, thereby maintaining high affinity and selectivity.
Solution Approach 2:
The patent introduces functional monomers or crosslinkers as intermediaries that bridge the polysaccharide backbone and the template molecule. These intermediary components provide additional functional groups (carboxyl, amino, hydroxyl) that enhance binding specificity and affinity, overcoming the limitations of polysaccharide repetitiveness while preserving biodegradability.
3Reliability
If protein building elements are used to enhance affinity and selectivity, then binding capacity is improved, but inflammatory responses are developed in in vivo applications
Solution Approach 1:
The patent employs short peptide sequences or amino acid-based building elements that are rapidly metabolized and cleared from the body, replacing long-lived protein structures. These shorter biodegradable units provide sufficient binding capacity during their brief functional lifetime but minimize immune recognition and inflammatory responses, effectively resolving the contradiction between binding performance and biocompatibility.
4Object-affected harmful factors
If natural polymers are used to improve biocompatibility, then degradability and reduced inflammatory responses are achieved, but manufacturing precision and control over binding sites are reduced
Solution Approach 1:
The patent incorporates the template molecule during the polymerization process of natural polymer building elements, allowing the binding sites to be pre-formed with precise geometry and functionality. This preliminary action ensures that even with natural polymer variability, the molecular imprinting process creates well-defined recognition sites with controlled properties, maintaining manufacturing precision while using biocompatible materials.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
This approach results in highly biocompatible and degradable nanomaterials with enhanced selectivity and versatility, suitable for various applications including medical, bioengineering, and molecular sensing, while minimizing inflammatory responses and environmental impact.
Implementation Method 1
said building elements being crosslinked through a photoinitiator in the presence of a template molecule
Implementation Method 2
the formation of covalent, or even non-covalent, interactions between a 'template molecule' (or templating agent) and a selection of functional monomers
Implementation Method 3
molecular cavities having a shape complementary to the template itself and in which the binding functional groups are immobilized in a spatial configuration that is complementary to the template molecule
Data Source
AI summary
A molecularly imprinted polymer in the form of nanoparticles, a method of preparation and uses thereof. Polymeric nanoparticles have recognition sites of at least one target molecule and are obtained by crosslinking of at least one polymer that is functionalized at least with polymerizable double bonds, in a liquid and in the presence of at least one target molecule as template molecule. Polymeric nanoparticles can be used for many applications, such as selective recognition of analytes, in vivo and in vitro targeting, labelling of biological molecules or in the preparation of molecular sensors.